Eloxx Pharmaceuticals Inc (NASDAQ:ELOX)
| 0.28 Delayed Data As of 3:59pm ET |  +0.02 / +7.69%Today’s Change | 0.21 Today|||52-Week Range 2.07 | -60.35% Year-to-Date |
Latest ELOX News | Press Releases
No recent news for Eloxx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.26 |
| Today’s open | 0.24 |
| Day’s range | 0.24 - 0.28 |
| Volume | 10,674 |
| Average volume (3 months) | 213,161 |
| Market cap | $20.9M |
Data as of 3:59pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | -10.69% |
| Earnings growth (this year) | +49.47% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GENEGenetic Technologies... | -0.05 | -4.28% |
| SNGXSoligenix Inc | +0.06 | +10.71% |
| APLTApplied Therapeutics... | +0.16 | +17.46% |
| TMBRTimber Pharmaceutica... | +0.01 | +2.81% |
Data as of 5:31pm ET, 06/29/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
